Biotech advance puts new life in joints  

Cell culture technique developed for treating damaged knee joints

A cooperation between two Copenhagen Regional Hospitals, Interface Biotech A/S, the Technological Institute and Øresunds Science Parks A/S has developed Cartilink-1, a new technology for cartilage implantation that can be used for knee operations.

Cartilink-1 is an orthopaedic surgery technology in which cartilage cells are first extracted from the patient's knee and then laboratory cultured for 3 to 4 weeks before being reinjected into the damaged area of the knee. In the US and Europe there are about 375,000 new cases of knee cartilage damage annually, of which Denmark accounts for 5,000.

Next step

Explore business cases

Please contact me

How can we help you?

We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×